DGCity
— A Window to China

A 400-Year-Old Malaria Remedy Becomes a Two-Handed Molecular Catalyst

Chemists at Westlake University in Hangzhou have given an ancient malaria medicine a second career. By reshaping cinchona alkaloid, the compound behind quinine, they built a new catalyst with two cooperating grips that can steer one of the most common bond-forming reactions in the chemical industry toward a single mirror-image product. The work appears in the Journal of the American Chemical Society.

The reaction in question, known as SN2, is chemistry’s version of a substitution play: one molecular group leaves a carbon atom while a new group attaches from the opposite side. Drug, pesticide and everyday-chemical factories rely on it constantly. The hard part is chirality. Many molecules, like human hands, come in two mirror forms that have identical formulas but behave very differently in the body; one mirror twin can be an effective medicine while the other is useless or even harmful. Catalysts that force an SN2 reaction to make only the desired hand have existed since the 1980s, built around positively charged quaternary ammonium salts, but for decades they only worked with a narrow menu of starting materials.

Cinchona alkaloid was an attractive scaffold because nature supplies it in a single handed form. South American indigenous peoples were treating fevers with cinchona bark in the 17th century, and quinine extracted from it became the first modern antimalarial, reaching into European colonial history as the bitter compound in tonic water. The Westlake group led by Deng Li has spent more than two decades modifying the molecule for catalysis. Adapting it to SN2, a substitution rather than the addition reactions the team knew, demanded a new architecture.

The breakthrough catalyst began as a curiosity synthesized back in 2023: a bis-quaternary ammonium salt carrying two charged centers instead of one. A crystal structure revealed why that mattered. An ordinary catalyst has a single grip; the new molecule had two grips joined by a rigid frame, suggesting it could hold both reacting partners at once and position them for each other. An early version worked but controlled the handedness imperfectly. Adding two tert-butyl groups to a biphenyl bridge stiffened the structure, and tuning temperature and additives produced the final catalyst, designated C7. One grip anchors a nitrogen-rich nucleophile through electrostatic and weak interactions, the other catches the bromine end of an alkyl bromide, and density-functional calculations confirmed the whole arrangement.

Tested across a wide range of substrates, the system proved notably unfussy, turning out chiral alpha,alpha-dialkyl aminonitrile compounds, molecules with a crowded four-bond stereocenter that chemists find difficult to assemble, and which can be converted into amides, amino-acid esters and diamines, common building blocks for pharmaceuticals. First authors Zeng Yiqun and Yu Yang combined experiments with theory; Southwest University of Science and Technology professor Luo Jisheng is a corresponding author alongside Deng.

The result matters beyond one reaction. It shows that an old natural product, cheap and historically storied, can be engineered into a cooperative two-site catalyst, a design principle the team expects to extend to other stubborn substitutions and to the broader push for cleaner synthesis that avoids producing the wrong-handed half of every batch.

Like(0)
未经允许不得转载:Dgcity » A 400-Year-Old Malaria Remedy Becomes a Two-Handed Molecular Catalyst

Sign In

Forgot Password

Sign Up